What is NDC 39822-0190?

39822-0190 is the product NDC for Acetazolamide, Acetazolamide sodium 500 mg/5mL injection, powder, lyophilized, for solution, listed with the FDA by XGen Pharmaceuticals DJB, Inc.. It has 1 package NDC, shown above in 10- and 11-digit form.

XGen Pharmaceuticals DJB, Inc., NDC labeler code 39822. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Acetazolamide?

70 other product NDCs are listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

Acetazolamide NDC 39822-0190 | National Drug Code

NDC codes

FDA NDC Directory

Product NDC (as listed)39822-0190Labeler and product segments. Claims need a package NDC.

Product NDC at billing width39822-0190Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
39822-0190-1	39822019001	1 VIAL, GLASS in 1 CARTON (39822-0190-1) / 5 mL in 1 VIAL, GLASSMarketed from Mar 1, 2009

How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Acetazolamide
Generic name (nonproprietary): acetazolamide
Active ingredients: Acetazolamide sodium — 500 mg/5mL
Dosage form: Injection, Powder, Lyophilized, For solution
Route: Intravenous
Labeler: XGen Pharmaceuticals DJB, Inc.NDC labeler code 39822
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 040784
Marketing start: Dec 10, 2008
Listing expires: Dec 31, 2026
Other FDA classes: Carbonic Anhydrase Inhibitors (Mechanism)Sulfonamides (Chemical structure)
Identifiers: Product ID 39822-0190_36974f91-0025-447d-e063-6294a90a0dc2SPL ID 36974f91-0025-447d-e063-6294a90a0dc2SPL set ID a9199d3c-ce52-4db5-aa36-408f4e15e344RxCUI 307702UNII 429ZT169UH
Pharmacologic class: Carbonic Anhydrase Inhibitor

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.

Administration

Drug administration (CPT 96360–96549)

When a clinician administers the drug, the administration is reported separately. Codes in this range cover hydration, therapeutic injections and infusions, and chemotherapy or other complex drug administration. The right code depends on route, duration and drug type, and self-administered drugs are not billed this way.

How CPT relates to drug billing

NDC on a medical claim

N439822019001 followed by a unit qualifier and the quantity

Package 39822-0190-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Jun 2, 2025.

Indications (excerpt from the label)

INDICATIONS AND USAGE For adjunctive treatment of: edema due to congestive heart failure; drug-induced edema; centrencephalic epilepsies (petit mal, unlocalized seizures); chronic simple (open-angle) glaucoma, secondary glaucoma, and preoperatively in acute angle-closure glaucoma where delay of surgery is desired in order to lower intraocular pressure.

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 39822-0190

What is NDC 39822-0190?: 39822-0190 is the product NDC for Acetazolamide, Acetazolamide sodium 500 mg/5mL injection, powder, lyophilized, for solution, listed with the FDA by XGen Pharmaceuticals DJB, Inc.. It has 1 package NDC, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: Acetazolamide.
What is the active ingredient?: Acetazolamide sodium.
Who is the labeler?: XGen Pharmaceuticals DJB, Inc., NDC labeler code 39822. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Acetazolamide?: 70 other product NDCs are listed under this name. See all Acetazolamide NDCs.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Other finished products listed under the same name: strengths, forms and labelers.

Other Acetazolamide NDCs
Product	Strength	Form · route	Labeler	Product NDC	Package NDCs (11-digit)
Acetazolamide	Acetazolamide 500 mg/1	Capsule, Extended releaseOral	REMEDYREPACK INC.	70518-4646	70518-4646-00
Acetazolamide	Acetazolamide 125 mg/1	TabletOral	Marlex Pharmaceuticals, Inc.	10135-830	10135-0830-01
Acetazolamide	Acetazolamide 250 mg/1	TabletOral	Marlex Pharmaceuticals, Inc.	10135-831	10135-0831-01
Acetazolamideacetazolamide sodium	Acetazolamide sodium 500 mg/5mL	Injection, Powder, For solutionIntravenous	Sagent Pharmaceuticals	25021-839	25021-0839-20
Acetazolamide	Acetazolamide sodium 500 mg/5mL	Injection, Powder, Lyophilized, For solutionIntravenous	Gland Pharma Limited	68083-661	68083-0661-01
Acetazolamide	Acetazolamide 250 mg/1	TabletOral	Aurobindo Pharma Limited	59651-906	59651-0906-01
Acetazolamide	Acetazolamide 125 mg/1	TabletOral	Aurobindo Pharma Limited	59651-905	59651-0905-01
Acetazolamide	Acetazolamide 125 mg/1	TabletOral	Aarkish Pharmaceuticals NJ Inc.	81005-104	81005-0104-0181005-0104-10
Acetazolamide	Acetazolamide 250 mg/1	TabletOral	Aarkish Pharmaceuticals NJ Inc.	81005-105	81005-0105-0181005-0105-10
Acetazolamide	Acetazolamide 125 mg/1	TabletOral	Ajanta Pharma USA Inc.	27241-132	27241-0132-04

All 71 Acetazolamide NDCs